ARCHIVES

Avastin Increases Overall Survival 3.7 Months

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

NCI To Evaluate Chernobyl Effects On Soviet Health

November 23, 1990

Conference Split Difference, NCI Gets $1.075 Billion

October 21, 1983

Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC

February 26, 2010

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

January 25, 2002

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

April 27, 2007

CTEP’s Clinical Trials Proposals Reshaped By Discussion: BSC Next On Schedule

May 9, 1986